MARKET

NLSP

NLSP

Nls Pharmaceutics Ltd
NASDAQ
1.950
-0.430
-18.07%
After Hours: 1.960 +0.01 +0.51% 19:55 12/20 EST
OPEN
2.230
PREV CLOSE
2.380
HIGH
2.285
LOW
1.780
VOLUME
262.54K
TURNOVER
--
52 WEEK HIGH
24.34
52 WEEK LOW
1.730
MARKET CAP
4.62M
P/E (TTM)
-0.2902
1D
5D
1M
3M
1Y
5Y
1D
NLS Pharmaceutics and Kadimastem Advance Diabetes Treatment with FDA Submission
TipRanks · 2d ago
NLS Pharmaceutics, Kadimastem submit request for FDA pre-IND meeting
TipRanks · 2d ago
NLS Pharmaceutics Plans Capital Increase at Extraordinary Shareholders’ Meeting
TipRanks · 3d ago
Weekly Report: what happened at NLSP last week (1209-1213)?
Weekly Report · 5d ago
NLS Pharmaceutics Advances DOXA Platform Amid Merger Plans
TipRanks · 12/11 17:02
NLS Pharmaceutics expects to close Kadimastem merger by end of January
TipRanks · 12/11 12:45
Which subsectors to own and which to avoid – Wolfe Research
Seeking Alpha · 12/10 18:33
Weekly Report: what happened at NLSP last week (1202-1206)?
Weekly Report · 12/09 09:57
More
About NLSP
NLS Pharmaceutics AG, formerly NLS 1 Pharma AG, is a Switzerland-based company that operates as a biopharmaceutical company. The Company focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The Company serves customers worldwide.

Webull offers NLS Pharmaceutics AG stock information, including NASDAQ: NLSP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NLSP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NLSP stock methods without spending real money on the virtual paper trading platform.